On April 15, 2026, the FDA updated its 503A bulk drug substances document, removing multiple peptides from Category 2 and scheduling them for PCAC evaluation
The primary materials discussed are various angiotensin peptides, their synthetic analogs, and specific receptor antagonists, while the methods encompass biochemical assays, animal models of neurodegenerative diseases, and behavioral assessments [2]
and ongoing follow-up supports dose titration and side-effect management
Overeating was a cue, weight was a symptom, a signal that we needed to pay attention
Fiber supplements, such as sugar-free Metamucil, can also be helpful, but check with your healthcare provider before using fiber supplements or stool softeners
Among the tested drugs, bezafibrate and C-75 Trans mitigated the ascites protection against ferroptosis